EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudie

Efficacy of CO2 laser vs vaginal estrogen in perimenopausal women with genitourinary syndrome of menopause: systematic review and meta-analysis

Aya Mohamed Nasr iD, Mohab Alsaid Saad iD, Amer Salah Mohamed iD, Yousif Ahmad Hanafi iD, Bilal Walid Bazbaz, Sarra Salah Amer Mohamed iD, Sayed Mahmoud Selim iD, Zaid Fatehi Altawallbeh iD

The Journal of Sexual Medicine · 04.08.2025 · 22 (8) · 1409-1421

DOI: 10.1093/jsxmed/qdaf153 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Journal of Sexual Medicine, online erschienen am 07.07.2025. Verfasst von Aya Mohamed Nasr und 7 weiteren Autor:innen. Beteiligte Einrichtung: Alexandria University Main Hospital, Alexandria, Egypt. Hauptthemen laut MEDLINE: Lasers, Gas, Estrogens, Perimenopause, Female Urogenital Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Genitourinary syndrome of menopause (GSM) is characterized by vaginal dryness, itching, burning, pain during intercourse, and urinary symptoms. Traditionally, hormone replacement therapy (HRT), specifically estrogen therapy, has been the first-line treatment for GSM, due to its side effects, fractional CO2 laser therapy has emerged as an alternative for managing GSM symptoms.

Aim

The primary focus is to compare CO2 fractional laser therapy and estrogen therapy on postmenopausal women with GSM through systemically reviewing all the randomized controlled trials.

Methods

A comprehensive search of electronic databases, including PubMed, Scopus, Web of Science, Medline, Cochrane, Scielo, UC Berkeley library, and Google Scholar, was performed in October 2024. The inclusion criteria targeted randomized controlled trials comparing CO2 fractional laser therapy and estrogen therapy on postmenopausal women with GSM, which used at least 1 of these outcomes: Female Sexual Function Index (FSFI), Vaginal Health Index, Visual Analog Score, and Urinary Distress Inventory 6.

Results

Out of 688 studies, 7 studies were included for final analysis with a total of 302 participants: 154 had CO2 fractional laser therapy with a mean age of 55.9 years, and 148 had estrogen therapy with a mean age of 57.2 years. The analysis revealed no statistically significant difference between CO2 laser and estrogen in Vaginal Health Index (mean difference [MD], 1.60; 95% CI, –0.36 to 3.56; P = .09), FSFI-total (MD, 0.10; 95% CI, –2.03 to 2.23; P = .93), and Urinary Distress Inventory 6 (MD, –3.18; 95% CI, –6.77 to 0.42; P = .08). We used a sensitivity analysis on the FSFI-arousal subscale due to high heterogeneity, excluding 1 study. It showed that the CO2 laser group had a statistically significant difference when compared with the estrogen group (MD, 0.47; 95% CI, 0.15-0.79; P = .01).

Conclusion

CO2 laser therapy is an effective line of treatment for GSM. However, its comparison with estrogen therapy did not reach a statistically significant difference favoring one line over the other.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lasers, GasEstrogensPerimenopauseFemale Urogenital DiseasesEstrogen Replacement TherapyVaginal DiseasesHumansFemaleAdministration, IntravaginalMiddle AgedMenopauseRandomized Controlled Trials as TopicSyndromeVagina

Stichwörter der Autor:innen

CO2 laserGSMestrogenfemale genital diseasesgenitourinary syndromelaser therapymenopausevaginal moisturizersvulvovaginal atrophy

Substanzen

Estrogens

Autor:innen und Institutionen

  • Alexandria University Main Hospital, Alexandria, Egypt.
  • Faculty of Medicine, Al-Azhar University, Cairo, 11884, Egypt.
  • Università degli Studi di Roma "La Sapienza," Rome, 00185, Italy.
  • The Hashemite University, Amman, 13115, Jordan.
  • Libyan International Medical University, Benghazi, 2181, Libya.
  • Department of Vascular Surgery, Al Azhar University Hospitals, Cairo, 11884, Egypt.

ORCID-Profile: Aya Mohamed Nasr, Mohab Alsaid Saad, Amer Salah Mohamed, Yousif Ahmad Hanafi, Sarra Salah Amer Mohamed, Sayed Mahmoud Selim, Zaid Fatehi Altawallbeh

Zitieren

APA

Nasr, A. M., Saad, M. A., Mohamed, A. S., Hanafi, Y. A., Bazbaz, B. W., Mohamed, S. S. A., Selim, S. M., & Altawallbeh, Z. F. (2025). Efficacy of CO2 laser vs vaginal estrogen in perimenopausal women with genitourinary syndrome of menopause: systematic review and meta-analysis. The Journal of Sexual Medicine, 22(8), 1409-1421. https://doi.org/10.1093/jsxmed/qdaf153

Vancouver

Nasr AM, Saad MA, Mohamed AS, Hanafi YA, Bazbaz BW, Mohamed SSA, et al. Efficacy of CO2 laser vs vaginal estrogen in perimenopausal women with genitourinary syndrome of menopause: systematic review and meta-analysis. The Journal of Sexual Medicine. 2025;22(8):1409-1421. doi:10.1093/jsxmed/qdaf153

BibTeX
@article{Nasr2025,
  author = {Nasr, Aya Mohamed and Saad, Mohab Alsaid and Mohamed, Amer Salah and Hanafi, Yousif Ahmad and Bazbaz, Bilal Walid and Mohamed, Sarra Salah Amer and Selim, Sayed Mahmoud and Altawallbeh, Zaid Fatehi},
  title = {Efficacy of CO2 laser vs vaginal estrogen in perimenopausal women with genitourinary syndrome of menopause: systematic review and meta-analysis},
  journal = {The Journal of Sexual Medicine},
  year = {2025},
  volume = {22},
  number = {8},
  pages = {1409--1421},
  doi = {10.1093/jsxmed/qdaf153}
}
Kostenlos starten →